Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aptinyx Inc
(NQ:
APTX
)
0.0610
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Aptinyx Inc
< Previous
1
2
3
4
Next >
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
Thursday saw 177 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
On Wednesday, 200 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 07, 2022
Gainers
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 25, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022
August 16, 2022
Via
Benzinga
Expert Ratings for Aptinyx
May 19, 2022
Within the last quarter, Aptinyx (NASDAQ:APTX) has observed the following analyst ratings:
Via
Benzinga
Expert Ratings for Aptinyx
April 21, 2022
Within the last quarter, Aptinyx (NASDAQ:APTX) has observed the following analyst ratings:
Via
Benzinga
What 4 Analyst Ratings Have To Say About Aptinyx
August 15, 2022
Over the past 3 months, 4 analysts have published their opinion on Aptinyx (NASDAQ:APTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 12, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 12, 2022
Via
Benzinga
Aptinyx Shares Plummet As Mid-Stage Fibromyalgia Study Missed Primary Endpoint
August 12, 2022
Aptinyx Inc. (NASDAQ: APTX) announced results from a Phase 2b clinical study evaluating the effects of NYX-2925 in patients with fibromyalgia. The Phase 2b clinical study was designed to evaluate the...
Via
Benzinga
Here's Why Aptinyx Stock Is Lower By Over 30% Friday
August 12, 2022
Aptinyx Inc (NASDAQ: APTX) shares are trading lower by 35.80% to $0.39 Friday morning after the company announced results from its Phase 2b Study of NYX-2925 did not achieve the primary endpoint. What...
Via
Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
August 15, 2022
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Via
Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
August 12, 2022
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.
Via
Benzinga
Aptinyx's Chronic Pain Candidate Fails To Top Placebo In Mid-Stage Study
August 12, 2022
Aptinyx Inc (NASDAQ: APTX) has announced results from a Phase 2b study evaluating the effects of NYX-2925 in patients with fibromyalgia, characterized by muscular or musculoskeletal pain with stiffness...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 12, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 08, 2022
Via
Benzinga
Aptinyx: Q2 Earnings Insights
August 04, 2022
Aptinyx (NASDAQ:APTX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Aptinyx beat estimated earnings by...
Via
Benzinga
Recap: Aptinyx Q1 Earnings
May 12, 2022
Aptinyx (NASDAQ:APTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Aptinyx beat estimated earnings by...
Via
Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
August 09, 2022
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.
Via
Benzinga
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
August 08, 2022
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...
Via
Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
June 28, 2022
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 03, 2022
During Friday's trading, 69 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 27, 2022
Via
Benzinga
90 Biggest Movers From Yesterday
May 10, 2022
Gainers
Via
Benzinga
26 Stocks Moving in Thursday's Pre-Market Session
April 21, 2022
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:...
Via
Benzinga
53 Biggest Movers From Yesterday
April 08, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail...
Via
Benzinga
Mid-Afternoon Market Update: S&P 500 Turns Positive; Aptinyx Shares Slide
April 07, 2022
U.S. stocks pared losses, with the Dow Jones and S&P 500 turning positive toward the end of trading on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 07, 2022
Gainers Trevi Therapeutics (NASDAQ:TRVI) stock rose 45.8% to $2.77 during Thursday's regular session. Trevi Therapeutics's stock is trading at a volume of 15.2...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
April 07, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.